UBS AM’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,843
| Closed | -$1.82M | – | 2948 |
|
|
2019
Q3 | $1.82M | Buy |
26,843
+6,351
| +31% | +$431K | ﹤0.01% | 1646 |
|
|
2019
Q2 | $1.19M | Buy |
20,492
+3,085
| +18% | +$179K | ﹤0.01% | 1817 |
|
|
2019
Q1 | $1.22M | Buy |
17,407
+4,592
| +36% | +$322K | ﹤0.01% | 1749 |
|
|
2018
Q4 | $825K | Buy |
12,815
+9,816
| +327% | +$632K | ﹤0.01% | 1826 |
|
|
2018
Q3 | $211K | Buy |
+2,999
| New | +$211K | ﹤0.01% | 2424 |
|
|
2016
Q4 | – | Sell |
-9,499
| Closed | -$275K | – | 2761 |
|
|
2016
Q3 | $275K | Hold |
9,499
| – | – | ﹤0.01% | 2312 |
|
|
2016
Q2 | $246K | Hold |
9,499
| – | – | ﹤0.01% | 2325 |
|
|
2016
Q1 | $235K | Sell |
9,499
-700
| -7% | -$17.3K | ﹤0.01% | 2354 |
|
|
2015
Q4 | $359K | Hold |
10,199
| – | – | ﹤0.01% | 2251 |
|
|
2015
Q3 | $216K | Hold |
10,199
| – | – | ﹤0.01% | 2450 |
|
|
2015
Q2 | $283K | Buy |
10,199
+600
| +6% | +$16.6K | ﹤0.01% | 2402 |
|
|
2015
Q1 | $293K | Buy |
9,599
+500
| +5% | +$15.3K | ﹤0.01% | 2277 |
|
|
2014
Q4 | $291K | Buy |
9,099
+1,300
| +17% | +$41.6K | ﹤0.01% | 2256 |
|
|
2014
Q3 | $221K | Hold |
7,799
| – | – | ﹤0.01% | 2315 |
|
|
2014
Q2 | $214K | Hold |
7,799
| – | – | ﹤0.01% | 2378 |
|
|
2014
Q1 | $205K | Hold |
7,799
| – | – | ﹤0.01% | 2411 |
|
|
2013
Q4 | $228K | Sell |
7,799
-300
| -4% | -$8.77K | ﹤0.01% | 2303 |
|
|
2013
Q3 | $248K | Hold |
8,099
| – | – | ﹤0.01% | 2205 |
|
|
2013
Q2 | $257K | Buy |
+8,099
| New | +$257K | ﹤0.01% | 2101 |
|